6 reports

  • GLOBAL NASAL DRUG DELIVERY MARKET
  • NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY END USER

The global nasal drug delivery technology market is projected to reach USD 64.20 billion by 2021 from USD 44.00 billion in 2016, at a CAGR of 6.5% during the forecast period. Increasing patient preference for nasal drug delivery as a result of easy administration & better efficacy and growing self-administration practices among the...

  • Drug Delivery
  • Nasal Drug Delivery
  • North America
  • United States
  • Market Size

A US MARKET REPORT ##.

  • Nasal Drug Delivery
  • OTC
  • Pharmaceutical
  • Therapy
  • United States
  • NAS020 - UNIDOSE NASAL DRUG DELIVERY DEVICE - PRODUCT DESCRIPTION
  • NAS020 - UNIDOSE NASAL DRUG DELIVERY DEVICE - PRODUCT STATUS

Transmucosal Drug Delivery - Medical Devices Pipeline Assessment, 2018 Summary GlobalData’s Medical Devices sector report, “Transmucosal Drug Delivery - Medical Devices Pipeline Assessment, 2018" provides an overview of Transmucosal Drug Delivery currently in pipeline stage. The report provides...

  • Anesthetics
  • Clinical Trial
  • Nasal Drug Delivery
  • Pharmaceutical
  • Opiant Pharmaceuticals, Inc.
  • PARTNERSHIPS

Summary Impel NeuroPharma Inc (Impel) is a clinical-stage biotechnology company that which develops intranasal drug treatments for central nervous system disorders.The company’s product pipeline includes INP104, INP103, INP102, INP101, INP105, and INP106. It also develops Precision Olfactory Delivery technology,...

  • Healthcare
  • Nasal Drug Delivery
  • Pharmaceutical
  • United States
  • Company

Sprays Nasal Drug Delivery Devices Types of Drug Delivery Devices Droppers Sprays Aerosol Containers/ Inhalers Pumps Nasal Aspirator Intranasal Drug Delivery Vis-à-vis Other Delivery Techniques Limitations of Intran

  • Nasal Drug Delivery
  • OTC
  • Pharmaceutical
  • Therapy
  • United States

Sprays Nasal Drug Delivery Devices Types of Drug Delivery Devices Droppers Sprays Aerosol Containers/ Inhalers Pumps Nasal Aspirator Intranasal Drug Delivery Vis-à-vis Other Delivery Techniques Limitations of Intran

  • Allergy Drug
  • Nasal Drug Delivery
  • OTC
  • Pharmaceutical
  • United States